Role of pharmacogenomics in the drug development

Beena S. Suvarna

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Individuals respond differently to drugs and sometimes the effects are unpredictable. Differences in DNA that alter the expression or function of proteins targeted by drugs can contribute significantly to the variation in the individuals responses. The use of pharmacogenomics is to identify genetic polymorphisms that predispose patients to adverse drug effects that, although they may occur in only a small subset of the people treated with a new medication, are sufficiently toxic to jeopardise further development of the drug for all patients. Given the potential value of knowing all the possible factors that influence the effects of new agents, it is likely that pharmacogenomics will have an increasingly important role in drug discovery and development. This article briefly reviews concepts that underlie the emerging fields of pharmacogenetics and pharmacogenomics, with an emphasis on the pharmacogenetics of drug metabolism. Although only a few examples will be provided to illustrate concepts and to demonstrate the potential contribution of pharmacogenetics to medical practice, it is now clear that virtually every pathway of drug metabolism will eventually be found to have genetic variation.

Original languageEnglish
Pages (from-to)172-176
Number of pages5
JournalKathmandu University Medical Journal
Volume7
Issue number26
Publication statusPublished - 01-04-2009
Externally publishedYes

Fingerprint

Pharmacogenetics
Pharmaceutical Preparations
Poisons
Genetic Polymorphisms
Drug Discovery
DNA
Proteins

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Suvarna, Beena S. / Role of pharmacogenomics in the drug development. In: Kathmandu University Medical Journal. 2009 ; Vol. 7, No. 26. pp. 172-176.
@article{004e14ec7acf44649cd0284919768616,
title = "Role of pharmacogenomics in the drug development",
abstract = "Individuals respond differently to drugs and sometimes the effects are unpredictable. Differences in DNA that alter the expression or function of proteins targeted by drugs can contribute significantly to the variation in the individuals responses. The use of pharmacogenomics is to identify genetic polymorphisms that predispose patients to adverse drug effects that, although they may occur in only a small subset of the people treated with a new medication, are sufficiently toxic to jeopardise further development of the drug for all patients. Given the potential value of knowing all the possible factors that influence the effects of new agents, it is likely that pharmacogenomics will have an increasingly important role in drug discovery and development. This article briefly reviews concepts that underlie the emerging fields of pharmacogenetics and pharmacogenomics, with an emphasis on the pharmacogenetics of drug metabolism. Although only a few examples will be provided to illustrate concepts and to demonstrate the potential contribution of pharmacogenetics to medical practice, it is now clear that virtually every pathway of drug metabolism will eventually be found to have genetic variation.",
author = "Suvarna, {Beena S.}",
year = "2009",
month = "4",
day = "1",
language = "English",
volume = "7",
pages = "172--176",
journal = "Kathmandu University Medical Journal",
issn = "1812-2027",
publisher = "Kathmandu University",
number = "26",

}

Role of pharmacogenomics in the drug development. / Suvarna, Beena S.

In: Kathmandu University Medical Journal, Vol. 7, No. 26, 01.04.2009, p. 172-176.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Role of pharmacogenomics in the drug development

AU - Suvarna, Beena S.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Individuals respond differently to drugs and sometimes the effects are unpredictable. Differences in DNA that alter the expression or function of proteins targeted by drugs can contribute significantly to the variation in the individuals responses. The use of pharmacogenomics is to identify genetic polymorphisms that predispose patients to adverse drug effects that, although they may occur in only a small subset of the people treated with a new medication, are sufficiently toxic to jeopardise further development of the drug for all patients. Given the potential value of knowing all the possible factors that influence the effects of new agents, it is likely that pharmacogenomics will have an increasingly important role in drug discovery and development. This article briefly reviews concepts that underlie the emerging fields of pharmacogenetics and pharmacogenomics, with an emphasis on the pharmacogenetics of drug metabolism. Although only a few examples will be provided to illustrate concepts and to demonstrate the potential contribution of pharmacogenetics to medical practice, it is now clear that virtually every pathway of drug metabolism will eventually be found to have genetic variation.

AB - Individuals respond differently to drugs and sometimes the effects are unpredictable. Differences in DNA that alter the expression or function of proteins targeted by drugs can contribute significantly to the variation in the individuals responses. The use of pharmacogenomics is to identify genetic polymorphisms that predispose patients to adverse drug effects that, although they may occur in only a small subset of the people treated with a new medication, are sufficiently toxic to jeopardise further development of the drug for all patients. Given the potential value of knowing all the possible factors that influence the effects of new agents, it is likely that pharmacogenomics will have an increasingly important role in drug discovery and development. This article briefly reviews concepts that underlie the emerging fields of pharmacogenetics and pharmacogenomics, with an emphasis on the pharmacogenetics of drug metabolism. Although only a few examples will be provided to illustrate concepts and to demonstrate the potential contribution of pharmacogenetics to medical practice, it is now clear that virtually every pathway of drug metabolism will eventually be found to have genetic variation.

UR - http://www.scopus.com/inward/record.url?scp=67649612858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649612858&partnerID=8YFLogxK

M3 - Review article

VL - 7

SP - 172

EP - 176

JO - Kathmandu University Medical Journal

JF - Kathmandu University Medical Journal

SN - 1812-2027

IS - 26

ER -